Lara Shirikjian
Psychiatry · Torrance, CANPI 1609193978
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 34.4% of the total. 2025 is the largest year on record at $311,231, more than ten times the $1,371 reported in 2019. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 678 payments — averaging $819.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$191K
- Axsome Therapeutics, Inc.$187K
- Johnson & Johnson$130K
- Boehringer Ingelheim International GmbH$28K
- Janssen Scientific Affairs, LLC$6K
- Boehringer Ingelheim$6K
- plus $7K from 6 others
Across 1,370 payments — averaging $8811.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Teva Pharmaceuticals USA, Inc.$3.6M
- AbbVie$1.9M
- Otsuka Pharmaceutical Development & Commercialization, Inc.$1.7M
- E.r. Squibb & Sons, L.L.C.$1.2M
- Sumitomo Pharma America, Inc.$1.2M
- Boehringer Ingelheim$792K
- plus $1.7M from 16 others
What the payments were for
- Consulting fees$147,68627%
- Speaking & faculty fees$324,01358%
- Travel & lodging$70,20913%
- Food & beverage$13,8482%
- Education$520%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 208 | $191,379 |
| Axsome Therapeutics, Inc. | 197 | $187,233 |
| Johnson & Johnson | 215 | $129,975 |
| Boehringer Ingelheim International GmbH | 7 | $28,311 |
| Janssen Scientific Affairs, LLC | 11 | $6,157 |
| Boehringer Ingelheim | 9 | $5,617 |
| Neurocrine Biosciences, Inc. | 11 | $2,164 |
| Janssen Global Services, LLC | 1 | $2,020 |
| Avanir Pharmaceuticals, Inc. | 13 | $1,371 |
| AbbVie | 3 | $868 |
| Biogen | 1 | $632 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $83 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$185,152
- SPRAVATO$130,747
- COBENFY$126,419
- INVEGA TRINZA$938
- VRAYLAR$190
How this compares
$555,808 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Torrance
- James PrattyTorrance$598K
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.